Click in for the latest news from The Hill.
By Adam Barnes A new study suggests Americans get less shut eye at age 40 than they do at any other point in their lives. Medical College of Georgia investigators used data from a sample of 11,279 participants aged 6 and older who wore a device on their wrist for 24 hours a day over a period of seven days. Researchers found that nighttime sleep declines with increasing age. |
© The Associated Press/ Evan Vucci |
By Gianna Melillo For patients who undergo kidney transplants, lifelong immunosuppression via medication is needed to ensure their immune systems do not reject the new organ. However, pediatricians at Stanford Medicine have now developed a method of carrying out kidney transplants in immunosuppressed children using stem cells from parents, negating the need for these drugs. |
© The Associated Press/Charlie Riedel |
By Gianna Melillo Amid extreme heat waves engulfing the nation and striking footage of floods deluging a national park, it's difficult to ignore the palpable effects of climate change already altering everyday life. In the following states, new bills, rules, and budgets have subtly incorporated climate action into agendas, marking incremental steps forward in the fight against climate change. |
By Joseph Guzman For 20 years, the Kennedy Center's VSA Emerging Young Artists Program has recognized and showcased the work of young disabled artists. After a lengthy delay due to the COVID-19 pandemic, the 2020-21 winners are finally being recognized. This year's theme, titled "Merge," called on young artists to contemplate the intersections of their creative process and disability identity through their art. |
|
|
© Carsten Koall/Getty Images |
By Chia-Yi Hou The Maryland-based company Novavax has a COVID-19 vaccine that is approved for emergency use internationally but not yet in the U.S. In the U.S., emergency use authorization could be on the way and provide a fourth vaccine option in addition to the two mRNA vaccines and the Johnson and Johnson vaccine. Nuvaxovid differs from the mRNA vaccines via Pfizer/BioNTech and Moderna. |
|
|
|
No comments:
Post a Comment